Regulatory, patent reform needed for inhalers for asthma, COPD
A pioneering study discovers an underlying cause for infantile spasms and points to a novel therapy
20 May 2022It’s ‘Kids to parks day’: get out, get active
21 May 2022Regulatory, patent reform needed for inhalers for asthma, COPD
Of the 62 inhalers approved by the U.S. Food and Drug Administration since 1986, few have offered novel drug innovations, according to a study published online May 17 in Health Affairs.
